New World Medical

New World Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

New World Medical is a privately held, commercial-stage medical device company specializing in surgical glaucoma solutions. With a 35+ year legacy originating from the invention of the Ahmed Glaucoma Valve, the company has built a comprehensive portfolio of implantable devices and surgical systems. It operates with a distinct humanitarian-focused business model, measuring success by 'patients served' and dedicating 10% of profits to philanthropic efforts via the Sidra Tree Foundation. Its products are available in over 78 countries.

OphthalmologyGlaucoma

Technology Platform

Portfolio of implantable glaucoma drainage devices (valved and non-valved), minimally invasive glaucoma surgical (MIGS) tools, and surgical support systems for ophthalmic surgery.

Opportunities

Significant growth lies in expanding adoption of its minimally invasive glaucoma surgery (MIGS) tools like the KDB GLIDE and STREAMLINE system, and in deepening penetration into underserved global markets where the glaucoma burden is high.
Its comprehensive portfolio allows for bundled solutions and stronger surgeon relationships.

Risk Factors

Faces intense competition from larger medical device companies and innovative startups in the glaucoma space.
Its humanitarian focus on low-margin markets could pressure financials, and the company relies heavily on the continued success of its flagship Ahmed Glaucoma Valve amidst evolving surgical standards.

Competitive Landscape

Operates in the competitive surgical glaucoma device market against major players like Alcon (Cypass, now withdrawn, and other devices), Johnson & Johnson Vision (iStent), and Glaukos (iStent inject, iDose). Also competes with other MIGS and drainage device companies such as Santen, Sight Sciences, and Ivantis.